Currently, oligonucleotide synthesis is built around phosphoramidite synthesis, which has inherent cost and scale limitations and involves the use of toxic organic solvents. Primrose Bio’s ...

The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, ...

(NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Arthur Levin, PhD, to the Company’s Strategic ...

(3) Chemicals cap unreacted 5’-hydroxyl groups. An oxidation step creates a more stable coupling. The oligonucleotide is ready for another round of synthesis. (4) Chemicals stabilize coupling. Once ...

GenScript’s strategy for saturation mutagenesis relies on programmable semiconductor chips, which are DNA synthesis platforms with high oligonucleotide synthesis capacity, combined with user ...

OSM stands for Oligonucleotide Synthesizer designed for use in Microgravity, meaning that it’s a device that makes arbitrary DNA strands (of moderate length) in space. Cool eh? I’ve been ...

From being a promising yet underexplored approach in the 1990s, mRNA therapeutics have evolved dramatically. The discovery of ...

Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...